Public Profile

Teva Pharmaceuticals

Teva Pharmaceuticals Industries Ltd., commonly known as Teva, is a global leader in the pharmaceutical industry, headquartered in Israel (IL). Founded in 1901, Teva has established a strong presence in over 60 countries, focusing on the development, production, and marketing of generic and specialty medicines. With a diverse portfolio that includes a wide range of therapeutic areas such as central nervous system disorders, oncology, and respiratory conditions, Teva is renowned for its commitment to accessibility and innovation. The company’s core products, including the widely used Copaxone and a robust selection of generic medications, set it apart in a competitive market. Teva's notable achievements include being one of the largest generic drug manufacturers globally, reflecting its significant market position and dedication to improving patient outcomes through affordable healthcare solutions.

DitchCarbon Score

How does Teva Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

85

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Teva Pharmaceuticals's score of 85 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Teva Pharmaceuticals's reported carbon emissions

In 2024, Teva Pharmaceuticals reported total greenhouse gas (GHG) emissions of approximately 4,066,116,000 kg CO2e across all scopes. This includes 243,603,000 kg CO2e from Scope 1 emissions and 218,504,000 kg CO2e from Scope 2 emissions (market-based). The company also disclosed significant Scope 3 emissions, amounting to about 4,066,116,000 kg CO2e, which primarily arise from purchased goods and services, use of sold products, and end-of-life treatment of sold products. Teva has set ambitious targets to reduce its carbon footprint. The company aims to achieve a 25% reduction in absolute Scope 1 and 2 GHG emissions by 2025 and a 46% reduction by 2030, using 2019 as the baseline year. Additionally, Teva has committed to reducing its absolute Scope 3 emissions by 25% by 2030, compared to 2020 levels. Furthermore, Teva has announced its intention to reach net zero emissions across its operations and value chain by 2045. These commitments align with industry standards and reflect Teva's proactive approach to addressing climate change and reducing its environmental impact. The company is actively working towards these targets, demonstrating a commitment to sustainability in the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201320142015201620172018201920202021202220232024
Scope 1
438,420,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
613,541,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Teva Pharmaceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Teva Pharmaceuticals is in IL, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Teva Pharmaceuticals is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Philips

NL
Computer and related services (72)
Updated 4 days ago

Adcock Ingram Holdings Limited

ZA
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Regeneron

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Fresenius Medical Care Holdings, Inc.

US
Health and social work services (85)
Updated 24 days ago
DitchCarbon Score

Haleon plc

GB
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers